![Reid Waldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reid Waldman
Fondateur chez
VERADERMICS, INCORPORATED
Fortune : 17 M $ au 31/08/2026
Profil
Reid Waldman is the founder of Veradermics, Inc., founded in 2019, holding the title of Chief Executive Officer & Director since 2022.
Dr. Waldman currently holds the position of Director at Achieve Life Sciences, Inc., starting in 2026.
Dr. Waldman completed undergraduate and doctorate degrees at the University of Missouri-Kansas City.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/08/2026 | 170 824 ( 0,41 % ) | 17 M $ | 31/08/2026 | |
| 27/07/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Reid Waldman
| Sociétés | Poste | Début |
|---|---|---|
| VERADERMICS, INCORPORATED | Fondateur | 01/01/2019 |
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 29/05/2026 |
Formation de Reid Waldman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Missouri-Kansas City
 University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
